New Jersey Health Reporter
SEE OTHER BRANDS

Get your health and wellness news from New Jersey

New Jersey Health Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Jersey Health Reporter.

Press releases published on June 24, 2025

Kayal Pain & Spine Center: The Leader in Endoscopic Spine Surgery

Kayal Pain & Spine Center: The Leader in Endoscopic Spine Surgery

NJ Top Docs reviewed and approved practice, Kayal Pain …

'Mastering Business Storytelling' by Taty Fittipaldi Released: A Guide for Global Executives to Lead with Influence

'Mastering Business Storytelling' by Taty Fittipaldi Released: A Guide for Global Executives to Lead with Influence

Now Available: Learn How Strategic Storytelling Can Transform Leadership, Business Influence, and Corporate Success DENVILLE, NJ, UNITED STATES, June 24, 2025 /⁨EINPresswire.com⁩/ -- Today marks the official release of Mastering Business Storytelling: How …

Thunai.ai Achieves #1 Ranking on Product Hunt, Validating its Leadership in Agentic Driven Customer Support

Thunai.ai Achieves #1 Ranking on Product Hunt, Validating its Leadership in Agentic Driven Customer Support

Thunai.ai, the pioneering Agentic AI platform for intelligent agent solutions, proudly announced today that it has achieved the #1 Product of the Day ranking. BRANCHBURG, NJ, INDIA, June 24, 2025 /⁨EINPresswire.com⁩/ -- Thunai.ai, the pioneering Agentic …

Syndax Announces FDA Priority Review of sNDA for Revuforj® (revumenib) in Relapsed or Refractory mNPM1 Acute Myeloid Leukemia

Syndax Announces FDA Priority Review of sNDA for Revuforj® (revumenib) in Relapsed or Refractory mNPM1 Acute Myeloid Leukemia

– PDUFA action date set for October 25, 2025 – – sNDA being reviewed under FDA’s RTOR program – – Revumenib has the potential to become the first and only menin inhibitor approved in both R/R mNPM1 AML and R/R KMT2Ar acute leukemia – NEW YORK, June 24, …

Abvance Therapeutics Secures Strategic Seed Financing & Leadership Expansion at ADA Scientific Sessions

Abvance Therapeutics Secures Strategic Seed Financing & Leadership Expansion at ADA Scientific Sessions

CHICAGO, June 24, 2025 (GLOBE NEWSWIRE) -- Abvance Therapeutics, a biotechnology company developing next-generation glucagon analogs and therapies to prevent hypoglycemia and improve glucose management, today announced the closing of its initial seed …

Virginia Beach Boy Shot in Head Finds Road to Recovery at Children's Hospital of The King's Daughters

Virginia Beach Boy Shot in Head Finds Road to Recovery at Children's Hospital of The King's Daughters

Norfolk, Virginia, June 24, 2025 (GLOBE NEWSWIRE) -- NORFOLK, Va. – Emily Rigsby and Steven Davis sat next to their son, Landyn, in the pediatric intensive care unit desperately watching for any sign that he would be OK. The 8-year-old had been playing …

Shiny Smile Veneers Named Top Snap-On Veneer Brand in the US by Independent Review Platforms

Shiny Smile Veneers Named Top Snap-On Veneer Brand in the US by Independent Review Platforms

Houston, TX, June 24, 2025 (GLOBE NEWSWIRE) -- Shiny Smile Veneers, a US-based provider of custom-made snap-on veneers, has once again been recognized as one of the top snap-on veneer brands in the country, this time by two leading dental product resources …

Carestream Demonstrates Commitment to Sustainability with Better Stands Silver Award at Hospitalar 2025

Carestream Demonstrates Commitment to Sustainability with Better Stands Silver Award at Hospitalar 2025

SÃO PAULO, June 24, 2025 (GLOBE NEWSWIRE) -- Carestream Health was honored with the Better Stands Silver Award at Hospitalar 2025, recognizing the company’s efforts towards sustainability and reducing its environmental footprint by implementing a reusable …

Multiple Sclerosis Clinical Trial Pipeline Shows Potential with Active Contributions from 60+ Key Companies | DelveInsight

Multiple Sclerosis Clinical Trial Pipeline Shows Potential with Active Contributions from 60+ Key Companies | DelveInsight

New York, USA, June 24, 2025 (GLOBE NEWSWIRE) -- Multiple Sclerosis Clinical Trial Pipeline Shows Potential with Active Contributions from 60+ Key Companies | DelveInsight Multiple Sclerosis, the most common neurological disorder in young adults, with …

Lulutox Tea UK (Lulutox Tea Detox) Officially Launches in Ireland, USA, Australia & Canada for Natural Digestive Cleanse

Lulutox Tea UK (Lulutox Tea Detox) Officially Launches in Ireland, USA, Australia & Canada for Natural Digestive Cleanse

New York City, June 24, 2025 (GLOBE NEWSWIRE) -- Lulutox™, a rising name in wellness and herbal nutrition, is excited to announce the official launch of its flagship product, Lulutox Detox Tea, across international markets including Ireland, the United …

PETVIVO HOLDINGS, INC. ANNOUNCES CLOSE OF PURCHASE OPTION TIED TO SERIES B CONVERTIBLE PREFERRED STOCK OFFERING

PETVIVO HOLDINGS, INC. ANNOUNCES CLOSE OF PURCHASE OPTION TIED TO SERIES B CONVERTIBLE PREFERRED STOCK OFFERING

MINNEAPOLIS, June 24, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) and its wholly-owned subsidiary PetVivo Animal Health, Inc. (collectively "PetVivo" or the “Company”) an emerging biomedical device company focused on the …

PruittHealth Certified as a Great Place to Work®

PruittHealth Certified as a Great Place to Work®

NORCROSS, Ga., June 24, 2025 (GLOBE NEWSWIRE) -- For the fourth consecutive year, PruittHealth, a leader in the Southeast for post-acute care and senior services, is officially certified as a Great Place to Work® for 2025. This prestigious recognition …

Hapbee Delivers Breakout Q1 2025: Record Growth, Leaner Operations, and a Clear Path to Scalable Profitability

Hapbee Delivers Breakout Q1 2025: Record Growth, Leaner Operations, and a Clear Path to Scalable Profitability

VANCOUVER, British Columbia, June 24, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies Inc. (TSXV: HAPB | OTCQB: HAPBF), (“Hapbee” or the “Company”), the digital wellness technology company pioneering the science of bio-streaming, announced today its …

Inventprise Announces Breakthrough in COVID-19 Conjugate Vaccine Study Published in Vaccine Journal

Inventprise Announces Breakthrough in COVID-19 Conjugate Vaccine Study Published in Vaccine Journal

REDMOND, Wash., June 24, 2025 (GLOBE NEWSWIRE) -- Inventprise, a clinical stage vaccine invention company, today announced the publication of a landmark preclinical study in Vaccine Journal (Vol. 54, April 30, 2025, Article 126988) showcasing the potential …

First Steroid Cycle 2025: Experts Discuss Science Behind Beginner’s Guide to Choise Best Steroids for Muscle Growth, Bulking & Cutting By CrazyBulk

First Steroid Cycle 2025: Experts Discuss Science Behind Beginner’s Guide to Choise Best Steroids for Muscle Growth, Bulking & Cutting By CrazyBulk

New York City, June 24, 2025 (GLOBE NEWSWIRE) -- How First-Time Users Can Build Muscle with Confidence’ Ultimate Beginner’s Guide to Steroid Cycles: Safe, Legal, and Effective Alternatives for Muscle Growth and Performance in 2025 Launches By CrazyBulk. …

National Fitness Partners Raises Over $24,000 for Make-A-Wish Foundation

National Fitness Partners Raises Over $24,000 for Make-A-Wish Foundation

CAMP HILL, Pa., June 24, 2025 (GLOBE NEWSWIRE) -- National Fitness Partners (NFP), a leading Planet Fitness franchisee, is proud to announce it has raised $24,121.61 in support of Make-A-Wish Foundation, helping grant life-changing wishes for children with …

Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech

Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech

CHICAGO, June 24, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R…

Fortrea und Emery Pharma kündigen strategische Zusammenarbeit zur Durchführung FDA-konformer Arzneimittelwechselwirkungsstudien mit Rifampin an

Fortrea und Emery Pharma kündigen strategische Zusammenarbeit zur Durchführung FDA-konformer Arzneimittelwechselwirkungsstudien mit Rifampin an

Durham, North Carolina, June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (das „Unternehmen“), ein führendes globales Auftragsforschungsinstitut (Contract Research Organization CRO), hat heute eine strategische Zusammenarbeit mit Emery Pharma …

Fortrea et Emery Pharma annoncent une collaboration stratégique visant à mener des études sur les interactions médicamenteuses répondant aux normes de la FDA en utilisant la rifampicine

Fortrea et Emery Pharma annoncent une collaboration stratégique visant à mener des études sur les interactions médicamenteuses répondant aux normes de la FDA en utilisant la rifampicine

DURHAM, Caroline du Nord, 24 juin 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq : FTRE) (la « Société »), une société de recherche contractuelle d’envergure mondiale (CRO) de premier plan, a annoncé aujourd’hui une collaboration stratégique avec Emery Pharma, …

Fortrea & Emery Pharma Umumkan Kolaborasi Strategis untuk Melakukan Studi Interaksi Obat-Obat yang Sesuai Peraturan FDA dengan Menggunakan Rifampin

Fortrea & Emery Pharma Umumkan Kolaborasi Strategis untuk Melakukan Studi Interaksi Obat-Obat yang Sesuai Peraturan FDA dengan Menggunakan Rifampin

DURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (“Perusahaan”), perusahaan riset berbasis kontrak (CRO) global terkemuka, hari ini mengumumkan kolaborasi strategis dengan Emery Pharma, CRO analitik dan bioanalitik terkemuka yang …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service